Hao, D.; Sengupta, A.; Ding, K.; Ubeydullah, E.; Krishnaiah, S.; Leighl, N.B.; Shepherd, F.A.; Seymour, L.; Weljie, A.
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy. Cancers 2020, 12, 1926.
https://doi.org/10.3390/cancers12071926
AMA Style
Hao D, Sengupta A, Ding K, Ubeydullah E, Krishnaiah S, Leighl NB, Shepherd FA, Seymour L, Weljie A.
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy. Cancers. 2020; 12(7):1926.
https://doi.org/10.3390/cancers12071926
Chicago/Turabian Style
Hao, Desirée, Arjun Sengupta, Keyue Ding, ER Ubeydullah, Saikumari Krishnaiah, Natasha B. Leighl, Frances A. Shepherd, Lesley Seymour, and Aalim Weljie.
2020. "Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy" Cancers 12, no. 7: 1926.
https://doi.org/10.3390/cancers12071926
APA Style
Hao, D., Sengupta, A., Ding, K., Ubeydullah, E., Krishnaiah, S., Leighl, N. B., Shepherd, F. A., Seymour, L., & Weljie, A.
(2020). Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy. Cancers, 12(7), 1926.
https://doi.org/10.3390/cancers12071926